| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/29/2026 | ±1.8% | +2.2% | under-priced |
| 04/29/2026 | ±2.2% | +5.8% | under-priced |
| 07/30/2025 | ±1.5% | -11.3% | under-priced |
| 05/01/2025 | ±2.4% | +0.7% | over-priced |
| 10/30/2024 | ±1.6% | +7.2% | under-priced |
| 08/01/2024 | ±2.2% | -5.8% | under-priced |
| 04/24/2024 | ±1.5% | -3.3% | under-priced |
| 10/26/2023 | ±2.6% | +3.3% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.93 | $921M | $143M |
| Q1 FY2026 | $1.61 | $887M | $120M |
| Q4 FY2025 | — | $0 | $0 |
| Q2 FY2025 | $1.74 | $865M | $131M |
IDEX Corporation (IEX) reports in 114 days, with the next report estimated for 01/04/2027. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 5.0% on average — the market has tended to under-price IEX's earnings risk. Fundamentals into the print: EPS up 53.2% year-over-year, revenue up 13.1%. QuantLogix's live 5-factor engine currently reads IEX as a buy at 65/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →